[Press Release by DSG]: DSG to attend Phar-East conference in Singapore

gwenda Event News Leave a Comment

FOR IMMEDIATE RELEASE MALVERN, PA., Feb. 19, 2018 – DSG, Inc., a leader in eClinical software and services to the life science industry will be exhibiting at the Phar-East – Asia’s Pharma & Biotech Conference. The conference is set to take place February 28th to March 2nd at the Suntec Signore Convention & Exhibition Centre, in Suntec City Singapore. Revamped …

Survey Report: Clinical Supply Trial Perspectives

gwenda Event News Leave a Comment

Healthcare’s swift movement toward a more patient-centric focus has forced the clinical trial landscape to adapt. Between complex supply chain support and changing government regulations, clinical trial sponsors and service providers are facing a multitude of challenges. In an effort to better understand these challenges faced by today’s clinical supply professionals, Catalent partnered with BioPharma Dive to survey and assess …

[Whitepaper]: Intravacc: bridging the vaccine development gap

gwenda Event News Leave a Comment

Intravacc Intravacc is a renowned, not-for-profit R&D organization with 100+ years’ experience in vaccine development. We develop vaccines, vaccine processes and vaccine technologies and substantially reduce the risks and costs involved with developing new vaccines. How? By bridging the gap between concept and late-stage clinical studies (see figure below). We have all the state-of-the-art facilities in house to offer you …

Regaining the confidence of Chinese biomanufacturing industry

Emily Event News Leave a Comment

Similar to other developing countries, the quality of Chinese bioproduction is often questioned by international markets due to various outbreak of scandals related to breach of quality protocols in production process. We invited Dr Amy Que, Vice President of Quality Control of Innovent Biologics, one of the leading innovation-driven biotech companies emphasizing on quality production to speak at the 10th BioPharma …

Chinese Biomanufacturing: Building “me-better” products in the competitive “me-too” market

Emily Event News Leave a Comment

Home to the largest population in the world and operating in a reimbursed environment, the humongous potential in the Chinese biopharmaceutical industry is impossible to ignore. But it’s also very competitive. At BioPharma Asia Convention 2017, we’ll be joined by leaders from innovation-driven biotech and pharma companies, as they share their strategies for surviving in the competitive Chinese market. Among …

Image taken from Roche website http://www.roche.com/research_and_development/drawn_to_science/target_identification.htm

Rethinking Drug Discovery & Research Models in India

Emily Event News Leave a Comment

Drug discovery is a high risk, high return business. Despite the intrinsic risks, pharma companies continue to invest heavily in R&D to improve the quality of life of patients in needs of treatment. While capital is important in R&D outcomes, innovation-based organisations need to understand the best model to adopt to speed up the process in bringing discoveries to useful commercial …

In photo: CTO of Biovalence Biotech, Mr EngHuan Ung

5 questions with Biovalence, a Malaysian biotech

Emily Event News Leave a Comment

At BioPharma Asia 2017, we invite 40 Asia biotech companies to present their innovative offerings in our new Biotech Innovation track. Among the participating companies is BioValence, Malaysia. Prior to the event, we asked EngHung Ung, CTO of BioValence to give you a preview on what you will expect to hear from them at the event. Q: Who is Biovalence and how is it disrupting the …

From “Make in India” to “Innovate in India”

Emily Event News Leave a Comment

With affordable and increasingly skilled labour, and a growing commitment to strengthening IPR and infrastructure within the country, India is now transforming itself from an API and generics manufacturer to an innovation-driven manufacturing hub. Pitching Prime Minister Narendra Modi’s ‘Make in India’ campaign in the United States, Mr. Dilip Shanghvi, the promoter, founder and CEO of Sun Pharmaceutical Industries, on …

NIHR CRN's white paper

UK’s clinical research network achieves 65 first global patients in 3 years

Lydia Sebastian Event News Leave a Comment

Performance figures show that the UK is open for business The National Institute for Health Research (NIHR) Clinical Research Network has reached a milestone in study set-up achievements by recruiting 65 first global patients in commercial studies in the last three years. With many clinical research studies recruiting patients simultaneously from all over the world, a “global first patient” is …

Managing issues in eClinical operation and design

Emily Event News Leave a Comment

With the potential for speeding up results and improving success rates, pharma companies are excited to roll out eClinical methods in their clinical trials in the hope of fast tracking the long, tiring, trial process for ensuring the safety of drugs for human consumption. But how do pharma personnel make sure that it really helps in creating successful trial result? Does …